In today’s fast-paced, innovation-fueled biopharma landscape, the traditional model of C-suite leadership is being turned on ...

One of the goals of the current administration is to implement the use of AI in FDA’s approval process. Proponents of the ...

The Medipost CEO discusses developing treatments for knee osteoarthritis and other conditions.

While the growing oncology pipeline offers tremendous potential, the path from clinical development through to commercial ...

Ekterly becomes the first FDA-approved oral on-demand treatment for hereditary angioedema in patients aged 12 years and older ...

The supplemental New Drug Application is supported by Phase III data, which showed Caplyta significantly prolonged time to ...

Biljana Naumovic, US President, oncology, solid tumor, Johnson & Johnson Innovative Medicine, outlines how the company is ...